Close Menu

NEW YORK – NeuMoDx Molecular said on Friday that it received CE-IVD marking for its assay to detect and differentiate Trichomonas vaginalis and/or Mycoplasma genitalium in clinical urine samples.

The Ann Arbor, Michigan-based company has launched the assay, which is for use with NeuMoDx Molecular systems. The assay leverages nucleic acid amplification technology for the automated detection of T. vaginalis and M. genitalium simultaneously.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.